Acurx Pharmaceuticals, Inc. $(ACXP)$, a biopharmaceutical company focusing on developing new antibiotics for challenging bacterial infections, has renewed its media partnership with New to The Street. The expanded agreement includes long-form televised interviews, national TV commercials, and participation in investor forums, aimed at increasing the company's visibility among investors. The partnership will feature Acurx on platforms such as Bloomberg Television, Fox Business, and social media, as well as providing direct access to accredited investors through exclusive events.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acurx Pharmaceuticals Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1069709) on September 06, 2025, and is solely responsible for the information contained therein.